 Company to host conference call and webcast on Thursday, August 27 at 8:30 am EDTLYON, France, August 19, 2020 - EDAP TMS SA Nasdaq: EDAP, the global leader in therapeutic ultrasound, today announced that it will release its financial results for the second quarter ended June 30, 2020 after the markets close on Wednesday, August 26, 2020.An accompanying conference call and webcast will be conducted by Marc Oczachowski, Chairman of the Board and Chief Executive Officer, and François Dietsch, Chief Financial Officer. The call will be held at 8:30am EDT on Thursday, August 27, 2020. Please refer to the information below for conference call dial-in information and webcast registration.Conference Call Webcast Thursday, August 27th 8:30am Eastern Time Domestic: 877-451-6152 International: 201-389-0879 Passcode: 13707833 Webcast: EDAP TMS SAA recognized leader in the global therapeutic ultrasound market for almost 40 years, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for urology using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One in 2013 in Europe and in 2018 in the US as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA-cleared Ablatherm Robotic HIFU and Ablatherm Fusion. As a pioneer and key player in the field of extracorporeal shock wave lithotripsy ESWL, EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith range of ESWL systems. For more information on the Company, please visit and us.hifu-prostate.com.CONTACTS: Blandine Confort Investor Relations Legal Affairs EDAP TMS SA 33 4 72 15 31 50 Contact Jeremy Feffer LifeSci Advisors, LLC 212-915-2568 